Home › Merck buys Swiss biotech with promising cancer drug
 

Keywords :   


Merck buys Swiss biotech with promising cancer drug

2014-12-18 19:05:10| Biotech - Topix.net

Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New Jersey, will pay up to $110 million upfront to OncoEthix.

Tags: drug cancer swiss promising

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
More »